The function of Runx1 in cardiac fibroblasts and post-myocardial infarction healing
Runx1在心肌成纤维细胞及心肌梗死后愈合中的作用
基本信息
- 批准号:10367400
- 负责人:
- 金额:$ 42.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAcuteBiological AssayCardiacCardiac MyocytesCell Differentiation processCell NucleusCell Proliferation RegulationCessation of lifeChondrocytesChondrogenesisCicatrixCommunicationCoupledDNA Polymerase IIEnhancersEpidermal Growth FactorEquilibriumExtracellular MatrixFibroblastsFibrosisFundingGene ExpressionGenesHeartHeart InjuriesHeart failureHi-CIn VitroInfarctionInjuryKnock-outKnockout MiceMaintenanceMass Spectrum AnalysisMediatingMitotic ActivityMolecularMusMyocardial InfarctionMyocardial ruptureMyocardiumMyofibroblastNatural regenerationOrganismPhasePlayPolymeraseProcessProliferatingProtein FamilyProtein IsoformsProteinsRNARegulationReportingResearchRoleSignal PathwaySignal TransductionStainsTamoxifenTechniquesTherapeuticTissuesTransforming Growth Factor betaUp-RegulationWild Type Mouseacute myeloid leukemia 1 proteinbone marrow mesenchymal stem cellcofactorconnective tissue growth factorcoronary fibrosishealingheart functionloss of functionnew therapeutic targetnon-complianceprematurepreventpromoterpublic health relevanceresponseresponse to injurytherapy developmenttranscriptome sequencingtreatment strategywound healing
项目摘要
Project Summary
Myocardial infarction (MI) induces the massive death of cardiomyocytes. Quiescent cardiac fibroblasts
(CFs) are rapidly activated after MI. They proliferate and differentiate into cardiac myofibroblasts (CMFs),
mediating cardiac fibrosis. We recently found that in more stabilized infarct scar CMFs further differentiate into
matrifibrocytes, a state resembling partially differentiated chondrocytes, which indicated an advanced level of
fibrosis. The post-MI fibrotic response in the heart stabilizes the infarcted myocardium, which may prevent
cardiac rupture but also reduce ventricle wall compliance and conductivity, and even interfere with regeneration
efforts. Understanding the mechanisms regulating post-injury CF activities will help the development of treatment
strategies that enhance the beneficial effect of CFs and inhibit their deleterious effects. We found that in response
to MI the expression of runt-related transcription factor 1 (Runx1) in CFs increased significantly during both
myofibroblast and matrifibrocyte differentiation. Our preliminary study showed that Runx1 promoted CF
proliferation and inhibited their differentiation into myofibroblasts in vitro. In addition, we identified Ccn2 as a
potential target of Runx1. Ccn2 plays multiple roles in the regulation of cell proliferation and differentiation
through interacting with different cofactors. Thus, we hypothesize that Runx1 functions to balance the
proliferation and myofibroblast differentiation of CFs during the acute phase of MI and promote matrifibrocyte
differentiation in more stabilized infarct scars through direct targeting Ccn2, which is critical for maintaining tissue
integrity but also promotes adverse remodeling. In Aim #1, CF-specific tamoxifen-inducible Runx1 knockout (KO)
mice and wild type mice will be subjected to MI injury. Immunohistochemical staining, RNA-seq, and functional
assay will be employed to study the function of Runx1 in the proliferation, myofibroblast differentiation, and
matrifibrocyte differentiation of CFs after MI. In Aim #2, the mechanism through which Runx1 regulates the
expression of Ccn2 will be studied using CUT&RUN, ATAC-seq, Hi-C, and co-IP coupled to mass spectrometry.
The unbiased approach will also identify other direct and indirect targets of Runx1. In Aim #3, CF-specific
tamoxifen-inducible Ccn2 KO mice will be employed to compare the effect of Ccn2 KO and Runx1 KO on CF
proliferation and differentiation after MI. The requirement of Ccn2 in the regulation of CF proliferation and
differentiation by Runx1 will also be studied. The synergistic effect between Ccn2 and its cofactors, HB-EGF and
TGFβ3, on cardiac fibroblast proliferation and differentiation will be studied as well.
项目摘要
心肌梗死(MI)可导致心肌细胞大量死亡。静止心肌成纤维细胞
(CFs)在心肌梗死后迅速激活。它们增殖并分化成心肌成纤维细胞(CMF),
介导心脏纤维化我们最近发现,在更稳定的梗死瘢痕中,CMFs进一步分化为
基质纤维细胞,一种类似于部分分化的软骨细胞的状态,这表明了一种先进的水平,
纤维化心肌梗死后的心脏纤维化反应稳定了梗死心肌,这可以防止心肌梗死。
心脏破裂还会降低心室壁顺应性和传导性,甚至干扰再生
努力了解损伤后CF活动的调节机制将有助于治疗的发展
增强CF的有益作用并抑制其有害作用的策略。我们发现,
MI时,CFs中Runx 1的表达显著增加,
肌成纤维细胞和基质纤维细胞分化。我们的初步研究表明,Runx 1促进CF
增殖并抑制其向肌成纤维细胞的分化。此外,我们将Ccn 2确定为
Runx 1的潜在目标。CCN 2在细胞增殖和分化的调节中起着多种作用
通过与不同的辅因子相互作用。因此,我们假设Runx 1的功能是平衡
心肌梗死急性期CFs的增殖和肌成纤维细胞分化,并促进基质纤维细胞
通过直接靶向Ccn 2,在更稳定的梗死瘢痕中分化,这对于维持组织
但也促进了不利的重塑。在目标#1中,CF特异性他莫昔芬诱导型Runx 1敲除(KO)
小鼠和野生型小鼠将遭受MI损伤。免疫组织化学染色,RNA-seq,和功能
本研究将采用免疫组化方法研究Runx 1在成肌纤维细胞增殖、分化和凋亡中的作用。
心肌梗死后CFs的基质纤维细胞分化。在目标#2中,Runx 1调节
Ccn 2的表达将使用CUT&RUN、ATAC-seq、Hi-C和co-IP与质谱联用来研究。
无偏方法还将识别Runx 1的其他直接和间接目标。在目标#3中,CF特定
将使用他莫昔芬诱导的Ccn 2 KO小鼠来比较Ccn 2 KO和Runx 1 KO对CF的影响
增殖和分化。Ccn 2在调节CF增殖和分化中的作用
还将研究Runx 1的分化。Ccn 2及其辅因子HB-EGF和HB-EGF之间的协同作用是通过调节Ccn 2的浓度来实现的。
TGFβ3对心脏成纤维细胞增殖和分化的影响也将进行研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xing Fu其他文献
Xing Fu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xing Fu', 18)}}的其他基金
The function of Runx1 in cardiac fibroblasts and post-myocardial infarction healing
Runx1在心肌成纤维细胞及心肌梗死后愈合中的作用
- 批准号:
10540749 - 财政年份:2021
- 资助金额:
$ 42.77万 - 项目类别:
Gene expression regulation mediating the activation and differentiation of cardiac fibroblasts and pulmonary fibroblasts after myocardial infarction
心肌梗死后介导心脏成纤维细胞和肺成纤维细胞活化和分化的基因表达调控
- 批准号:
10434447 - 财政年份:2021
- 资助金额:
$ 42.77万 - 项目类别:
Tcf21 and visceral adipose tissue development and expansion
Tcf21 和内脏脂肪组织的发育和扩张
- 批准号:
9813320 - 财政年份:2019
- 资助金额:
$ 42.77万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 42.77万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 42.77万 - 项目类别:
Operating Grants